These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36103908)

  • 1. CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer.
    Wang B; Wang M; Ao D; Wei X
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188799. PubMed ID: 36103908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of CXCL13/CXCR5 axis aggravates experimental autoimmune cystitis and interstitial cystitis/bladder pain syndrome.
    Zhao J; Chen S; Yang C; Zhou M; Yang T; Sun B; Zhu J; Zhang H; Lu Q; Li L; Yang Z; Song B; Shen W; Yi S; Dai S
    Biochem Pharmacol; 2022 Jun; 200():115047. PubMed ID: 35452631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ETV4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis.
    Gao X; Jiang M; Chu Y; Han Y; Jin Y; Zhang W; Wang W; Yang S; Li W; Fan A; Cao J; Wang J; Liu H; Fu X; Chen D; Nie Y; Fan D
    Cancer Lett; 2022 Jan; 524():42-56. PubMed ID: 34582976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXC chemokine ligand-13 promotes metastasis via CXCR5-dependent signaling pathway in non-small cell lung cancer.
    Chao CC; Lee WF; Wang SW; Chen PC; Yamamoto A; Chang TM; Weng SL; Liu JF
    J Cell Mol Med; 2021 Oct; 25(19):9128-9140. PubMed ID: 34427969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.
    Razis E; Kalogeras KT; Kotoula V; Eleftheraki AG; Nikitas N; Kronenwett R; Timotheadou E; Christodoulou C; Pectasides D; Gogas H; Wirtz RM; Makatsoris T; Bafaloukos D; Aravantinos G; Televantou D; Pavlidis N; Fountzilas G
    Clin Breast Cancer; 2012 Jun; 12(3):183-93. PubMed ID: 22607768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL13 Signaling in the Tumor Microenvironment.
    Hussain M; Liu J; Wang GZ; Zhou GB
    Adv Exp Med Biol; 2021; 1302():71-90. PubMed ID: 34286442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway.
    Zhu Z; Zhang X; Guo H; Fu L; Pan G; Sun Y
    Mol Cell Biochem; 2015 Feb; 400(1-2):287-95. PubMed ID: 25476740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL13/CXCR5 signaling axis in cancer.
    Hussain M; Adah D; Tariq M; Lu Y; Zhang J; Liu J
    Life Sci; 2019 Jun; 227():175-186. PubMed ID: 31026453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection.
    Cagigi A; Mowafi F; Phuong Dang LV; Tenner-Racz K; Atlas A; Grutzmeier S; Racz P; Chiodi F; Nilsson A
    Blood; 2008 Dec; 112(12):4401-10. PubMed ID: 18780835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Expression of CXCL13 and CXCR5 in Intractable Temporal Lobe Epilepsy Patients and Pilocarpine-Induced Epileptic Rats.
    Li R; Ma L; Huang H; Ou S; Yuan J; Xu T; Yu X; Liu X; Yang J; Chen Y; Peng X
    Neurochem Res; 2017 Feb; 42(2):526-540. PubMed ID: 27873133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis.
    Trolese MC; Mariani A; Terao M; de Paola M; Fabbrizio P; Sironi F; Kurosaki M; Bonanno S; Marcuzzo S; Bernasconi P; Trojsi F; Aronica E; Bendotti C; Nardo G
    EBioMedicine; 2020 Dec; 62():103097. PubMed ID: 33161233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the CXCL13/CXCR5 Axis in Autoimmune Diseases.
    Pan Z; Zhu T; Liu Y; Zhang N
    Front Immunol; 2022; 13():850998. PubMed ID: 35309354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RelA driven co-expression of CXCL13 and CXCR5 is governed by a multifaceted transcriptional program regulating breast cancer progression.
    Biswas S; Roy Chowdhury S; Mandal G; Purohit S; Gupta A; Bhattacharyya A
    Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):502-511. PubMed ID: 30553016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13.
    Zanetti C; Kumar R; Ender J; Godavarthy PS; Hartmann M; Hey J; Breuer K; Weissenberger ES; Minciacchi VR; Karantanou C; Gu Z; Roberts KG; Metzler M; Stock W; Mullighan CG; Bloomfield CD; Filmann N; Bankov K; Hartmann S; Hasserjian RP; Cousins AF; Halsey C; Plass C; Lipka DB; Krause DS
    Blood; 2021 Nov; 138(19):1870-1884. PubMed ID: 34424946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The healing myocardium mobilizes a distinct B-cell subset through a CXCL13-CXCR5-dependent mechanism.
    Heinrichs M; Ashour D; Siegel J; Büchner L; Wedekind G; Heinze KG; Arampatzi P; Saliba AE; Cochain C; Hofmann U; Frantz S; Campos Ramos G
    Cardiovasc Res; 2021 Nov; 117(13):2664-2676. PubMed ID: 34048536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome Network Analysis Identifies CXCL13-CXCR5 Signaling Modules in the Prostate Tumor Immune Microenvironment.
    Ohandjo AQ; Liu Z; Dammer EB; Dill CD; Griffen TL; Carey KM; Hinton DE; Meller R; Lillard JW
    Sci Rep; 2019 Oct; 9(1):14963. PubMed ID: 31628349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of chemokine (C-X-C motif) ligand 13 in spinal cord ischemia-reperfusion injury in rats.
    Chen F; Li X; Li Z; Zhou Y; Qiang Z; Ma H
    Brain Res; 2020 Jan; 1727():146489. PubMed ID: 31589828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Kinase C Epsilon Cooperates with PTEN Loss for Prostate Tumorigenesis through the CXCL13-CXCR5 Pathway.
    Garg R; Blando JM; Perez CJ; Abba MC; Benavides F; Kazanietz MG
    Cell Rep; 2017 Apr; 19(2):375-388. PubMed ID: 28402859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond.
    Kazanietz MG; Durando M; Cooke M
    Front Endocrinol (Lausanne); 2019; 10():471. PubMed ID: 31354634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF.
    Harrer C; Otto F; Pilz G; Haschke-Becher E; Trinka E; Hitzl W; Wipfler P; Harrer A
    Fluids Barriers CNS; 2021 Aug; 18(1):40. PubMed ID: 34446066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.